Lovisenberg Diakonale Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT01997138
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Lovisenberg Diakonale Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

anakinra (kineret) (1 trial)

Drugs in Other Trials (2)

human fecal microbiota (Reybota) (1 trial)

xylometazoline (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Knee Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3